article Open Access
Diagnostic utility of immunohistochemistry using basal cell markers in distinguishing benign from malignant prostatic lesions
International Journal of Clinical and Diagnostic Pathology · 2019 · Vol. 2(2) · pp. 05–07
Abstract
Immunohistochemical detection of basal cells plays a significant role in the diagnosis or exclusion of prostatic carcinoma in diagnostically challenging cases. The objective of this research is to study the expression of immunohistochemical markers p63 and high molecular weight cytokeratin (34βE12) in various prostatic lesions and comparing the sensitivity and specificity of 34βE12 and p63 in prostatic lesions. This was a cross sectional study carried out in our institution on 40 cases of prostatic lesions. It was found that p63 is more sensitive than HMWCK in identifying the basal cells in diagnostically challenging cases.
Prostate Cancer Treatment and ResearchUrologic and reproductive health conditionsProstate Cancer Diagnosis and TreatmentImmunohistochemistryCytokeratinPathologyBasal (medicine)MedicineBasal cellInternal medicine
Citations
0
FWCI
0.00
field-weighted impact
References
2
Percentile
18%
vs. same field & year
References
p63 Is a Prostate Basal Cell Marker and Is Required for Prostate Development
American Journal Of Pathology · 2000 · 608 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.